ACADIAN ASSET MANAGEMENT LLC - LOGICBIO THERAPEUTICS INC ownership

LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 45 filers reported holding LOGICBIO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$13,000
-27.8%
50,3390.0%0.00%
Q2 2022$18,000
-43.8%
50,3390.0%0.00%
Q1 2022$32,000
+113.3%
50,339
+2327.1%
0.00%
Q4 2019$15,0002,0740.00%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Lion Point Capital, LP 500,000$2,470,0000.65%
Orbimed Advisors 6,466,783$31,946,0000.54%
SAMLYN CAPITAL, LLC 798,566$3,945,0000.10%
ADAGE CAPITAL PARTNERS GP, L.L.C. 915,355$4,522,0000.01%
IHT Wealth Management, LLC 11,660$58,0000.01%
FIDUCIARY TRUST CO 37,998$188,0000.01%
FRANKLIN RESOURCES INC 700,000$3,458,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 13,700$68,0000.00%
Tower Research Capital LLC (TRC) 2,249$11,0000.00%
MANCHESTER FINANCIAL INC 200$1,0000.00%
View complete list of LOGICBIO THERAPEUTICS INC shareholders